The Reagent Grade Cordycepin Market continues to gain significant momentum as biomedical researchers and pharmaceutical developers increasingly recognize the therapeutic potential of this unique nucleoside analog derived from Cordyceps militaris and related fungal species. With cordycepin (3'-deoxyadenosine) demonstrating promising anti-inflammatory, anti-tumor, immunomodulatory, and anti-viral...